Changcheng Shi
- Co-authors
- Nengming LinQingyu LiYaping XieJunbo XiaYubo XiaoLimin WangJian YeZhi‐Chun Gu
- Topics
- Antimicrobial Resistance in Staphylococcus (4 papers)Antifungal resistance and susceptibility (3 papers)COVID-19 Clinical Research Studies (3 papers)
In The Last Decade
Changcheng Shi
13 papers receiving 342 citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 236
- Epidemiology 96
- Pharmacology 65
- Oncology 55
- Neurology 47
Countries citing papers authored by Changcheng Shi
This map shows the geographic impact of Changcheng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changcheng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changcheng Shi more than expected).
Fields of papers citing papers by Changcheng Shi
This network shows the impact of papers produced by Changcheng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changcheng Shi. The network helps show where Changcheng Shi may publish in the future.
Co-authorship network of co-authors of Changcheng Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Changcheng Shi. A scholar is included among the top collaborators of Changcheng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changcheng Shi. Changcheng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 12 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 111 | |
| 9 | 28 | |
| 10 | 24 | |
| 11 | 7 | |
| 12 | 22 | |
| 13 | 55 | |
| 14 | 39 | |
| 15 | 37 | |
| 16 | Meta-analysis of efficacy and safety of huperzine A for treatment of Alzheimer's disease | 2 |
About Changcheng Shi
Changcheng Shi is a scholar working on Infectious Diseases, Clinical Biochemistry and Pharmacology, having authored 16 papers that have together received 347 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (4 papers), Antifungal resistance and susceptibility (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (236 citations), Clinical Biochemistry (45 citations) and Pharmacology (37 citations). Changcheng Shi has collaborated with scholars based in China and Canada. Frequent co-authors include Nengming Lin, Qingyu Li, Yaping Xie, Junbo Xia, Yubo Xiao, Limin Wang, Jian Ye, Zhi‐Chun Gu, Renjie Xu and Jing Wu. Their work appears in journals such as PLoS ONE, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.